Geoffrey Shouse, D.O., Ph.D.'s is a board certified hematologist/oncologist and physician scientist who focuses his research on eliminating the barriers of lymphoma cure. He is the primary investigator on numerous clinical trials including utilizing cutting edge treatments to more effectively treat lymphoma. These include cell therapies, molecular targeted therapies and immunotherapy. In addition, he leads studies designed to improve outcomes in older adults facing the sometimes daunting toxicities of lymphoma therapy. Finally, he designs and implements clinical trials focused on enhanced access and recruitment of underrepresented minorities.

Dr. Shouse's fascination with molecular biology led him to hematology and oncology as a career. He earned a Ph.D. in cell, molecular and developmental biology at the University of California Riverside, and went on to study medicine at Western University of Health Sciences in Pomona, California. He continued his residency and fellowship training at Loma Linda University Medical Center, with additional fellowship training at City of Hope in stem cell transplant and cellular therapy.